The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Real‐world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review
Open accessAbstract
Aims: To identify real‐world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus. Methods: A literature search was conducted in PubMed and EMBASE in November 2011 to identify studies reporting factors associated with adherence/non‐adherence to insulin therapy in adults with Type 1 or Type 2 diabetes. Results: Seventeen studies were identified; six used self‐reported measures and 11 used calculated measures of adherence. Most (13/17) were conducted exclusively in the USA. Four categories of factors associated with non‐adherence were identified: predictive factors for non‐adherence, patient‐perceived barriers to adherence, type of delivery device and cost of medication. For predictive factors and patient‐perceived barriers, only age, female sex and travelling were associated with non‐adherence in more than one study. Fear of injections and embarrassment of injecting in public were also cited as reasons for non‐adherence. Conversely, adherence was improved by initiating therapy with, or switching to, a pen device (in four studies), and by changing to an insurance scheme that lowered the financial burden on patients (in two studies). Conclusions: Adherence to insulin therapy is generally poor. Few factors or patient‐perceived barriers were consistently identified as predictive for non‐adherence, although findings collectively suggest that a more flexible regimen may improve adherence. Switching to a pen device and reducing patient co‐payments appear to improve adherence. Further real‐world studies are warranted, especially in countries other than the USA, to identify factors associated with non‐adherence and enable development of strategies to improve adherence to insulin therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Direction and impact of language bias in meta-analyses of controlled trials: empirical study
Jüni, P., Holenstein, F., Sterne, J., Bartlett, C., & Egger, M. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.115 · Cited by 892
National Standards for Diabetes Self-Management Education and Support
Haas, L., Maryniuk, M., Beck, J., Cox, C. E., Duker, P., Edwards, L., Fisher, E. B., Hanson, L., Kent, D., Kolb, L., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1707 · Cited by 663
Steinsbekk, A., Rygg, L., Lisulo, M., Rise, M. B., & Fretheim, A. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-213 · Cited by 660
Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03605.x · Cited by 655
Is Glycemic Control Improving in U.S. Adults?
Hoerger, T. J., Segel, J. E., Gregg, E. W., & Saaddine, J. B. (2008) · Diabetes Care · doi:10.2337/dc07-1572 · Cited by 477
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407
Broadbent, E., Donkin, L., & Stroh, J. C. (2011) · Diabetes Care · doi:10.2337/dc10-1779 · Cited by 307
Multifaceted Determinants for Achieving Glycemic Control
Chan, J. C. N., Gagliardino, J. J., Baik, S. H., Chantelot, J.-M., Ferreira, S. R. G., Hancu, N., Ilkova, H., Ramachandran, A., Aschner, P., & on behalf of the IDMPS Investigators (2009) · Diabetes Care · doi:10.2337/dc08-0435 · Cited by 291
Self-citationLee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.004 · Cited by 266
How patient cost-sharing trends affect adherence and outcomes: a literature review.
Eaddy, M. T., Cook, C. L., O'Day, K., Burch, S. P., & Cantrell, C. R. (2012) · Europe PMC (PubMed Central) · Cited by 255
The effect of cost on adherence to prescription medications in Canada
Law, M. R., Cheng, L., Dhalla, I. A., Heard, D., & Morgan, S. G. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111270 · Cited by 232
Tshiananga, J. K. T., Kocher, S., Weber, C., Erny-Albrecht, K., Berndt, K., & Neeser, K. (2012) · The Diabetes Educator · doi:10.1177/0145721711423978 · Cited by 209
Patient Perspective on Factors Contributing to Nonadherence to Diabetes Regimen
Ary, D. V., Toobert, D., Wilson, W., & Glasgow, R. E. (1986) · Diabetes Care · doi:10.2337/diacare.9.2.168 · Cited by 183
National Standards for Diabetes Self-Management Education and Support
Haas, L. B., Maryniuk, M. D., Beck, J. K., Cox, C. E., Duker, P. N., Edwards, L., Fisher, E. B., Hanson, L., Kent, D., Kolb, L. E., et al. (2012) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721712455997 · Cited by 169
Measuring Psychological Insulin Resistance
Larkin, M., Capasso, V. A., Chen, C., Mahoney, E. K., Hazard, B. P., Cagliero, E., & Nathan, D. M. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708317869 · Cited by 160
Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes
Ross, S. A., Tildesley, H. D., & Ashkenas, J. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.621416 · Cited by 152
Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic Control
Nichols, G. A., Koo, Y. H., & Shah, S. N. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0139-y · Cited by 137
Prevalence and risk factors of retinal vein occlusion in an Asian population
Lim, L. L., Cheung, N., Wang, J. J., Islam, A. F. M., Mitchell, P., Saw, S., Aung, T., & Wong, T. Y. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.140640 · Cited by 122
Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control.
Joshi, S., Das, A. K., Vijay, V. J., & Mohan, V. (2008) · PubMed · Cited by 121
Self-citationPawaskar, M. D., CAMACHO, F. T., Anderson, R. T., Cobden, D., Joshi, A. V., & Balkrishnan, R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.007 · Cited by 111
Smith, C. B., Choudhary, P., Pernet, A., Hopkins, D., & Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-2259 · Cited by 106
Practical Aspects of Insulin Pen Devices
Pearson, T. L. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400304 · Cited by 95
Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004
Dodd, A. H., Colby, M. S., Boye, K. S., Fahlman, C., Kim, S. W., & BRIEFEL, R. R. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902973300 · Cited by 91
Gulliford, M. C., Ashworth, M. J., Robotham, D., & Mohiddin, A. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02090.x · Cited by 85
Egede, L. E., Gebregziabher, M., Hunt, K. J., Axon, R. N., Echols, C. L., Gilbert, G. E., & Mauldin, P. D. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p442 · Cited by 80
Vaghela, P. D., Ashworth, M. J., Schofield, P., & Gulliford, M. C. (2008) · Diabetes Care · doi:10.2337/dc08-1999 · Cited by 65
Başer, O., Bouchard, J. R., DeLuzio, T., Henk, H. J., & Aagren, M. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0009-6 · Cited by 56
Buysman, E. K., Conner, C., Aagren, M., Bouchard, J. R., & Liu, F. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.598500 · Cited by 45
Barriers to the initiation of, and persistence with, insulin therapy
Oliveria, S. A., Menditto, L. A., Yood, M. U., Koo, Y. H., Wells, K. E., & McCarthy, B. D. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x242638 · Cited by 45
Nonadherence to Insulin Therapy in Low-Income, Type 2 Diabetic Patients
Lerman, I. G., Díaz, J. P. M., Romero-Ibarguengoitia, M. E., Pérez, F. J. G., Villa, A. R., Velasco, M. L., Cruz, R. G., & Rodrigo, J. A. R. (2009) · Endocrine Practice · doi:10.4158/ep.15.1.41 · Cited by 40
A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
Xie, L., Wei, W., Pan, C., Du, J., & Başer, O. (2011) · Advances in Therapy · doi:10.1007/s12325-011-0074-5 · Cited by 32
Lee, L. J., Li, Q., Reynolds, M. W., Pawaskar, M. D., & Corrigan, S. M. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2010.546466 · Cited by 25
A Review of Insulin Pen Devices
McCoy, E. K., & Wright, B. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2145 · Cited by 22
Cuddihy, R. M., & Borgman, S. K. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318217a5e3 · Cited by 22
Nair, K. V., Miller, K., Saseen, J. J., Wolfe, P., Allen, R. R., & Park, J. (2009) · Europe PMC (PubMed Central) · Cited by 19
Psychosocial Factors Influencing Inner City Black Diabetic Patients' Adherence with Insulin
Uzoma, C. U., & Feldman, R. H. L. (1989) · Health Education · doi:10.1080/00970050.1989.10622385 · Cited by 14
Cited by
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Self-citationNonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Haddad, P., Brain, C., & Scott, J. (2014) · Patient Related Outcome Measures · doi:10.2147/prom.s42735 · Cited by 585
Adherence to diabetes medication: a systematic review
Krass, I., Schieback, P., & Dhippayom, T. (2015) · Diabetic Medicine · doi:10.1111/dme.12651 · Cited by 453
The pharmacology and therapeutic applications of monoclonal antibodies
Castelli, M. S., McGonigle, P., & Hornby, P. J. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.535 · Cited by 364
Identification of barriers to insulin therapy and approaches to overcoming them
Russell‐Jones, D., Pouwer, F., & Khunti, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13132 · Cited by 238
Self-citation
Metadata
- Authors
- Davies, M. J., Gagliardino, J. J., Gray, L. J., Khunti, K., Mohan, V., & Hughes, R.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2013-04-15
- Volume
- 30
- Issue
- 5
- Pages
- 512-524
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2106049537
- Cited by
- 294
- References
- 44
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.